Janus Henderson Group’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-43,850
Closed -$175K 2429
2025
Q4
$175K Hold
43,850
﹤0.01% 2365
2025
Q3
$370K Hold
43,850
﹤0.01% 2124
2025
Q2
$494K Hold
43,850
﹤0.01% 1957
2025
Q1
$421K Hold
43,850
﹤0.01% 2049
2024
Q4
$493K Hold
43,850
﹤0.01% 2044
2024
Q3
$1.24M Sell
43,850
-8,400
-16% -$217K ﹤0.01% 1558
2024
Q2
$998K Sell
52,250
-569
-1% -$14.5K ﹤0.01% 1619
2024
Q1
$1.73M Sell
52,819
-23,596
-31% -$753K ﹤0.01% 1350
2023
Q4
$2.52M Sell
76,415
-9,120
-11% -$258K ﹤0.01% 1117
2023
Q3
$2.33M Buy
85,535
+18,051
+27% +$502K ﹤0.01% 1103
2023
Q2
$2.04M Buy
67,484
+33,235
+97% +$1.07M ﹤0.01% 1234
2023
Q1
$1.11M Buy
34,249
+16,838
+97% +$532K ﹤0.01% 1569
2022
Q4
$489K Sell
17,411
-9,813
-36% -$281K ﹤0.01% 1728
2022
Q3
$980K Buy
27,224
+9,805
+56% +$345K ﹤0.01% 1654
2022
Q2
$537K Buy
17,419
+24
+0.1% +$699 ﹤0.01% 1721
2022
Q1
$562K Buy
17,395
+15
+0.1% +$393 ﹤0.01% 1831
2021
Q4
$480K Buy
17,380
+8,736
+101% +$251K ﹤0.01% 1912
2021
Q3
$268K Buy
+8,644
New +$208K ﹤0.01% 1950
2017
Q3
Sell
-150,000
Closed -$3.8M 1302
2017
Q2
$3.8M Buy
+150,000
New +$3.61M ﹤0.01% 1018

Other funds holding EVH

Janus Henderson Group's EVH Position: Q1 2026 in Review

Janus Henderson Group sold out of Evolent Health (EVH) in Q1 2026, closing a stake of 43,850 shares — an estimated $175K sold.

Janus Henderson Group first reported a position in EVH in Q2 2017 and held it in 19 quarters. The position peaked at $3.8M in Q2 2017. 191 funds tracked by Wall St. Rank hold EVH as of Q1 2026.

  • Janus Henderson Group reported no remaining Evolent Health position as of Q1 2026 after selling out during the quarter.
  • Janus Henderson Group sold 43,850 Evolent Health shares in Q1 2026, an estimated $175K.
  • Janus Henderson Group first reported a position in Evolent Health in Q2 2017 and held it in 19 quarters.
  • Janus Henderson Group's Evolent Health position peaked at $3.8M in Q2 2017.
  • 191 funds tracked by Wall St. Rank held Evolent Health as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.